This bioactive molecule can lead to the activation of PI3K/Akt/mTOR [34] insulin receptor substrate 1 (through IRS-1) phosphorylation, promoting insulin signalling pathway activation and thereby reducing insulin resistance [49]. The gene discussed is AKT1; the disease is Insulin resistance.